NASDAQ:VXRT   Vaxart, Inc. - Common Stock
I'll be purchasing calls for a $20 Strike expiring Jan.15th 2021. The CDC recently informed states to be ready to distribute Covid 19 vaccines by November 1st. With Vaxart still needing FDA approval they could see a major run soon.

Things to Keep in Mind
Vaxart is the only COVID-19 vaccine developer, among those mentioned in operation wrap speed, that has"next generation" oral tablet vaccines. According to Vaxart, its oral vaccines have been shown to be safe and well-tolerated and have the potential to generate a broad and durable immunity (systemic and mucosal), having been safely trialed in >460 humans, across 3 viral diseases.


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.